Werfen and Oxford Nanopore enter strategic collaboration to support development of advanced transplant assays

Werfen, global leader in specialized diagnostics, has announced a strategic collaboration with Oxford Nanopore Technologies to validate Werfen’s specialized transplant assay portfolios for use on Oxford Nanopore’s sequencing platforms.

The collaboration combines Werfen’s validated transplant assays with Oxford Nanopore’s sequencing technology to deliver fast, high-resolution results, essential for precise donor-recipient matching. It also streamlines and provides validated “sample-to-answer” workflows, making advanced assays more accessible to laboratories worldwide.

“This expanded agreement reflects Werfen’s confidence in Oxford Nanopore as a scalable, flexible platform for molecular assays. What began as a focused collaboration has evolved into a broader collaboration with a global leader, creating meaningful opportunities to extend the impact of nanopore sequencing across an expanding range of applications over time.” — Thomas Bray, Vice President, Corporate Business Development at Oxford Nanopore Technologies

Read the Werfen announcement here: https://www.werfen.com/en/werfen-and-oxford-nanopore-enter-strategic-collaboration-support-development-advanced-transplant